Has anyone heard of the clinical trials that are to start in Switzerland for Atexakin Slfa as the first disease modifying drug for neuropathic? Hoping to reduce pain, improve nerve conductivity and nerve regeneration. Does sound a little too good to be true - but we can hope.
Relief Theraputics are the company licences to start clinical trials